Cargando…
Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
In the present study, we have taken the novel approach of using an in vitro model representative of tamoxifen-withdrawal subsequent to clinical relapse to achieve a greater understanding of the mechanisms that serve to maintain the resistant-cell phenotype, independent of any agonistic impact of tam...
Autores principales: | Stone, Andrew, Valdés-Mora, Fatima, Gee, Julia M. W., Farrow, Lynne, McClelland, Richard A., Fiegl, Heidi, Dutkowski, Carol, McCloy, Rachael A., Sutherland, Robert L., Musgrove, Elizabeth A., Nicholson, Robert I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393679/ https://www.ncbi.nlm.nih.gov/pubmed/22808167 http://dx.doi.org/10.1371/journal.pone.0040466 |
Ejemplares similares
-
Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells
por: McCloy, R A, et al.
Publicado: (2013) -
Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer.
por: Sharma, A. K., et al.
Publicado: (1994) -
Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007) -
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy.
por: McClelland, R. A., et al.
Publicado: (1998) -
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1
por: Hutcheson, Iain R, et al.
Publicado: (2011)